What is iCardin?
Headquartered in Maharashtra, iCardin operates as a comprehensive healthcare discovery platform, offering end-to-end care solutions for patients afflicted with a spectrum of neurological disorders. The company collaborates with leading neurologists, neurosurgeons, and physicians across India to deliver critical emergency care and a range of services for conditions including epilepsy, Alzheimer's, dementia, Parkinson's disease, and migraines. iCardin's strategic positioning in the healthcare ecosystem aims to streamline patient journeys and enhance access to specialized neurological treatment.
How much funding has iCardin raised?
iCardin has raised a total of $100K across 1 funding round:
Unspecified
$100K
Unspecified (2021): $100K, investors not publicly disclosed
What's next for iCardin?
The recent large-scale, late-stage funding infusion positions iCardin for accelerated growth and expansion. This strategic capital is expected to fuel advancements in its technology platform, broaden its service offerings, and potentially extend its geographical reach within India and beyond. The company is poised to further solidify its role as a key player in addressing the complex needs of patients with neurological conditions, leveraging its partnerships and innovative approach to healthcare delivery.
See full iCardin company page
